Aurobindo Pharma has reported results for third quarter ended December 31, 2023 (Q3FY24).
The company has reported over 2-fold jump in its net profit at Rs 623.78 crore for the third quarter ended December 31, 2023 as compared to Rs 298.82 crore for the same quarter in the previous year. Total income of the company increased by 23.95% at Rs 3023.16 crore for Q3FY24 as compared Rs 2438.92 crore for corresponding quarter of the previous year.
On consolidated basis, the company has reported 91.44% rise in net profit at Rs 939.97 crore for Q3FY24 as compared to Rs 491.01 crore for the same quarter in the previous year. Total income of the company increased by 15.61% at Rs 7514.30 crore for Q3FY24 as compared Rs 6499.78 crore for corresponding quarter of the previous year.
